Jonathan Moss to Male
This is a "connection" page, showing publications Jonathan Moss has written about Male.
Connection Strength
0.158
-
Identifying and Treating Opioid Side Effects: The Development of Methylnaltrexone. Anesthesiology. 2019 01; 130(1):142-148.
Score: 0.033
-
Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer. Ann Oncol. 2016 11; 27(11):2032-2038.
Score: 0.028
-
Methylnaltrexone (Relistor®) does not impact opioid-mediated analgesia at therapeutic doses. Pain. 2014 Dec; 155(12):2722.
Score: 0.024
-
Effect of perioperative opioids on cancer recurrence: a hypothesis. Future Oncol. 2010 Aug; 6(8):1237-42.
Score: 0.018
-
Reversal of opioid-induced gastric dysfunction in a critically ill burn patient after methylnaltrexone. Anesth Analg. 2008 Dec; 107(6):1965-7.
Score: 0.016
-
Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans. J Clin Pharmacol. 2005 May; 45(5):538-46.
Score: 0.013
-
Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial. Ann Intern Med. 2004 Jul 06; 141(1):23-7.
Score: 0.012
-
Overexpression of the µ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis. Anesthesiology. 2012 Apr; 116(4):857-67.
Score: 0.005
-
Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation. Am J Respir Cell Mol Biol. 2007 Aug; 37(2):222-31.
Score: 0.004
-
Safety and tolerability of Ganoderma lucidum in healthy subjects: a double-blind randomized placebo-controlled trial. Am J Chin Med. 2007; 35(3):407-14.
Score: 0.004